✦ LIBER ✦

Phase II Study of Megestrol Acetate for Metastatic Carcinoma of the Prostate

✍ Scribed by CATHERINE CROMBIE; D. RAGHAVAN; J. PAGE; R. WOODS; D. DALLEY; RHONDA DEVINE; M. ROSEN

Book ID: 115193965
Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 302 KB
Volume: 59
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.1987.tb04843.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of megestrol acetate in t

Phase II study of megestrol acetate in the treatment of hepatocellular carcinoma

✍ YEE CHAO; WING-KAI CHAN; SUN-SANG WANG; KWOK-HUNG LAI; CHIN-WEN CHI; CHING-YUANG 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB

Megestrol acetate for treatment of advan

Megestrol acetate for treatment of advanced carcinoma of the prostate

✍ Douglas E. Johnson; Kelly E. Kaesler; Alberto G. Ayala 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB

Phase II study of lonidamine in metastat

Phase II study of lonidamine in metastatic prostatic carcinoma

✍ David J. Stewart; Susan E. Aitken; Allen H. Irvine; David E. Moors; Norman G. Fu 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 132 KB

A phase I/II study of high-dose megestro

A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer

✍ Howard L. Parnes; Jeffrey S. Abrams; N. Simon Tchekmedyian; Nancy Tait; Joseph A 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 543 KB

A phase II randomized trial of megestrol

A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate

✍ S. R. Patel; L. K. Kvols; R. G. Hahn; H. Windschitl; R. Levitt; T. Therneau 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB 👁 2 views

Phase II trial of tamoxifen in metastati

Phase II trial of tamoxifen in metastatic carcinoma of the prostate

✍ John H. Glick; Alan Wein; Kristin Padavic; William Negendank; David Harris; Harv 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 551 KB

Fifty-one patients with advanced metastatic carcinoma of the prostate were treated with the antiestrogen tamoxifen. Thirty-eight of these patients were refractory to prior hormonal manipulation with estrogens and/or orchiectomy, and five (13%) achieved an objective response (partial regression or st